Tenderwize
Back to tender search

Open House contract for Glycopyrronium bromide/Formoterol

Techniker Krankenkasse·Hamburg, Germany·Deadline Jul 30, 2027 · 346 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-18 - Glycopyrroniumbromid/Formoterol (Wirkstoffkombination)

46/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

46 / 100

Complexity

58 / 100

Risk factors

The notice says contracts cannot be submitted via the procurement portal; they must be sent by email with qualified ele...

Only pharmaceutical companies meeting the AMG-based eligibility conditions for the specific medicines may participate.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until Jul 2027
  • Conclude supply contracts for pharmaceutical products relating to Glycopyrroniumbromid/Formoterol.
  • Provide the relevant medicines for the German market nationwide.
Show full summary

Open House supply arrangement for pharmaceutical products concerning Glycopyrroniumbromid/Formoterol. The Techniker Krankenkasse seeks to conclude non-exclusive contracts with all suitable pharmaceutical companies under uniform conditions; no individual negotiations are held. The notice states that participation documents are only provided to companies that market or credibly intend to market the relevant medicines during the contract period. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post. The procedure is described as not being a public procurement contract in the usual sense, so standard procurement review routes are said not to apply.

Risks

The notice says contracts cannot be submitted via the procurement portal; they must be sent by email with qualified ele...

Only pharmaceutical companies meeting the AMG-based eligibility conditions for the specific medicines may participate.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Applicant must be a pharmaceutical company within the meaning of § 4 Abs. 18 AMG for the relevant medicines.
  • Applicant must have its seat in Germany, another EU Member State, or another EEA State.
  • Applicant must hold a valid marketing authorisation for the relevant medicines or otherwise be entitled to place them on the market in its own name.

Buyer

Location

Hamburg, DEU

Identifier

992-80116-93

Activity

Health

Lots (1)

LOT-0001

Open House contract for Glycopyrronium bromide/Formoterol

Supply arrangement for the drug combination Glycopyrroniumbromid/Formoterol. Scope is nationwide in Germany. The lot is an Open House Originale contract with uniform terms, no exclusivity, and no individual negotiations. The contract can be joined at any time during the contract period, subject to the stated eligibility conditions and document requirements. Source: structured data and XML notice.

SuppliesEU fundedElectronic submission

Location

DE600, Germany

Duration

Jul 2025 - Jul 2027

Category

Pharmaceutical products

Deadline

Deadline Jul 30, 2027

Procurement Details

Publication date
11 May 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
299868-2025

Documents (1)

Similar tenders